These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20388035)
1. Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer. Wiser I; Orr N; Kaufman B; Segev S; Smetana Z; Bialik A; Epstein N; Mendelson E; Catane R; Cohen D J Infect Dis; 2010 May; 201(10):1527-34. PubMed ID: 20388035 [TBL] [Abstract][Full Text] [Related]
2. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination. Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294 [TBL] [Abstract][Full Text] [Related]
3. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations. Hatakeyama S; Moriya K; Saijo M; Morisawa Y; Kurane I; Koike K; Kimura S; Morikawa S Clin Diagn Lab Immunol; 2005 Apr; 12(4):520-4. PubMed ID: 15817760 [TBL] [Abstract][Full Text] [Related]
5. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing. Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675 [TBL] [Abstract][Full Text] [Related]
6. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response. Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115 [TBL] [Abstract][Full Text] [Related]
7. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination. Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471 [TBL] [Abstract][Full Text] [Related]
8. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340 [TBL] [Abstract][Full Text] [Related]
9. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492 [TBL] [Abstract][Full Text] [Related]
10. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. Treanor J; Wu H; Liang H; Topham DJ Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939 [TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain. Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395 [TBL] [Abstract][Full Text] [Related]
12. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. Ennis FA; Cruz J; Demkowicz WE; Rothman AL; McClain DJ J Infect Dis; 2002 Jun; 185(11):1657-9. PubMed ID: 12023773 [TBL] [Abstract][Full Text] [Related]
14. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus. Kim SH; Bang JW; Park KH; Park WB; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW J Infect Dis; 2006 Aug; 194(3):377-84. PubMed ID: 16826487 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of human immunological responses to vaccinia virus. Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020 [TBL] [Abstract][Full Text] [Related]
16. Serological Immunity to Smallpox in New South Wales, Australia. Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R Viruses; 2020 May; 12(5):. PubMed ID: 32443405 [TBL] [Abstract][Full Text] [Related]
17. Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. Kan VL; Manischewitz J; King LR; Golding H AIDS; 2007 Feb; 21(4):521-4. PubMed ID: 17301573 [TBL] [Abstract][Full Text] [Related]
18. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. McCurdy LH; Larkin BD; Martin JE; Graham BS Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622 [TBL] [Abstract][Full Text] [Related]
19. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917 [TBL] [Abstract][Full Text] [Related]
20. [Development of a numerically additive combined vaccine against tetanus and smallpox]. Mayr A; Baljer G; Wagner C; Sailer J Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]